FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2492878939> ?p ?o ?g. }

• W2492878939 endingPage "312" @default.
• W2492878939 startingPage "305" @default.
• W2492878939 abstract "We developed a novel topical non-steroidal anti-inflammatory drug (NSAID)patch, S(+)-flurbiprofen plaster, (SFPP), containing S(+)-flurbiprofen (SFP), an enantiomer of flurbiprofen (FP). In a previous study conducted in an animal model, we showed good skin absorption and potent analgesic efficacy of SFPP. In this study, to examine the superior features, as an NSAID patch, of SFP as compared to FP and R(-)-flurbiprofen (RFP), we tested the stereospecificity of SFP actions on Prostaglandin E2 (PGE2) inhibition in rat inflammatory leukocytes and in the binding activity of the drug to cells, and also the in vitro skin permeability of the drug in the Yucatan micropig (YMP). SFP showed potent inhibitory activity on PGE2 production from peritoneal leukocytes stimulated with a bacterial suspension, as compared to RFP and FP. The half maximal (50%) inhibitory concentration (IC50) values were 14 nM for SFP, 52 nM for FP, and 17,000 nM for RFP. In the cell binding study, significant and rapid increase of SFP binding to polymorphonuclear leucocytes (PMNs) was observed at 5 min after incubation, eventually reaching a steady state. SFP showed significantly higher binding activity for the inflammatory leucocytes as compared to RFP, suggesting its superior transfer potency. The skin permeability profile of SFP, RFP and FP in the YMP model showed that the rank order of the cumulative amount of permeated compounds in the skin was SFP > RFP > FP. The steady-state permeation rate (Flux) of SFP was significantly higher than that of FP (4.89 and 1.55 mg/cm2/h, respectively, p = 0.0068), indicating the remarkably superior skin permeability of SFP. SFP exerted potent inhibitory activity on PGE2 production and superior binding activity to the PMNs and skin permeability, as compared to FP and RFP. These results suggest that SFP possesses favorable characteristics for use as an active ingredient in the NSAID patch." @default.
• W2492878939 created "2016-08-23" @default.
• W2492878939 creator A5011348147 @default.
• W2492878939 creator A5026595203 @default.
• W2492878939 creator A5030793371 @default.
• W2492878939 creator A5038577533 @default.
• W2492878939 creator A5043689424 @default.
• W2492878939 creator A5049846518 @default.
• W2492878939 creator A5055851227 @default.
• W2492878939 creator A5059048184 @default.
• W2492878939 creator A5065594730 @default.
• W2492878939 date "2016-01-01" @default.
• W2492878939 modified "2023-10-02" @default.
• W2492878939 title "S(+)-Flurbiprofen Shows Potent PGE2 Inhibitory Activity in Inflammatory Cells, Superior Cell Transport Activity and Skin Permeability" @default.
• W2492878939 cites W1845638336 @default.
• W2492878939 cites W1970668375 @default.
• W2492878939 cites W2033765046 @default.
• W2492878939 cites W2058032105 @default.
• W2492878939 cites W2063229676 @default.
• W2492878939 cites W2080475427 @default.
• W2492878939 cites W2101698887 @default.
• W2492878939 cites W2120285683 @default.
• W2492878939 cites W2125327054 @default.
• W2492878939 cites W2125699784 @default.
• W2492878939 cites W2164845015 @default.
• W2492878939 cites W2185291866 @default.
• W2492878939 cites W2344631517 @default.
• W2492878939 cites W294105292 @default.
• W2492878939 cites W4293247451 @default.
• W2492878939 doi "https://doi.org/10.4236/pp.2016.78037" @default.
• W2492878939 hasPublicationYear "2016" @default.
• W2492878939 type Work @default.
• W2492878939 sameAs 2492878939 @default.
• W2492878939 citedByCount "4" @default.
• W2492878939 countsByYear W24928789392017 @default.
• W2492878939 countsByYear W24928789392018 @default.
• W2492878939 countsByYear W24928789392022 @default.
• W2492878939 crossrefType "journal-article" @default.
• W2492878939 hasAuthorship W2492878939A5011348147 @default.
• W2492878939 hasAuthorship W2492878939A5026595203 @default.
• W2492878939 hasAuthorship W2492878939A5030793371 @default.
• W2492878939 hasAuthorship W2492878939A5038577533 @default.
• W2492878939 hasAuthorship W2492878939A5043689424 @default.
• W2492878939 hasAuthorship W2492878939A5049846518 @default.
• W2492878939 hasAuthorship W2492878939A5055851227 @default.
• W2492878939 hasAuthorship W2492878939A5059048184 @default.
• W2492878939 hasAuthorship W2492878939A5065594730 @default.
• W2492878939 hasBestOaLocation W24928789391 @default.
• W2492878939 hasConcept C126322002 @default.
• W2492878939 hasConcept C17077164 @default.
• W2492878939 hasConcept C185592680 @default.
• W2492878939 hasConcept C202751555 @default.
• W2492878939 hasConcept C2777752497 @default.
• W2492878939 hasConcept C2777956040 @default.
• W2492878939 hasConcept C2781000538 @default.
• W2492878939 hasConcept C55493867 @default.
• W2492878939 hasConcept C57992300 @default.
• W2492878939 hasConcept C71924100 @default.
• W2492878939 hasConcept C98274493 @default.
• W2492878939 hasConceptScore W2492878939C126322002 @default.
• W2492878939 hasConceptScore W2492878939C17077164 @default.
• W2492878939 hasConceptScore W2492878939C185592680 @default.
• W2492878939 hasConceptScore W2492878939C202751555 @default.
• W2492878939 hasConceptScore W2492878939C2777752497 @default.
• W2492878939 hasConceptScore W2492878939C2777956040 @default.
• W2492878939 hasConceptScore W2492878939C2781000538 @default.
• W2492878939 hasConceptScore W2492878939C55493867 @default.
• W2492878939 hasConceptScore W2492878939C57992300 @default.
• W2492878939 hasConceptScore W2492878939C71924100 @default.
• W2492878939 hasConceptScore W2492878939C98274493 @default.
• W2492878939 hasIssue "08" @default.
• W2492878939 hasLocation W24928789391 @default.
• W2492878939 hasOpenAccess W2492878939 @default.
• W2492878939 hasPrimaryLocation W24928789391 @default.
• W2492878939 hasRelatedWork W1033667931 @default.
• W2492878939 hasRelatedWork W148851648 @default.
• W2492878939 hasRelatedWork W1895256094 @default.
• W2492878939 hasRelatedWork W1981077546 @default.
• W2492878939 hasRelatedWork W2014005116 @default.
• W2492878939 hasRelatedWork W2019370793 @default.
• W2492878939 hasRelatedWork W2150823738 @default.
• W2492878939 hasRelatedWork W2335162015 @default.
• W2492878939 hasRelatedWork W2855363159 @default.
• W2492878939 hasRelatedWork W4285199141 @default.
• W2492878939 hasVolume "07" @default.
• W2492878939 isParatext "false" @default.
• W2492878939 isRetracted "false" @default.
• W2492878939 magId "2492878939" @default.
• W2492878939 workType "article" @default.